Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

Vir Biotechnology, Inc. today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is designed to evaluate the efficacy and ...

While the FDA, European Medicines Agency (EMA), and the UK’s Medicines and ... the failure or significant delay to submit safety variations to update the safety sections of Summaries of Product ...

Despite policies, guidelines, and regulations to promote the diversification of clinical trial groups by the European Medicines Agency (EMA) and FDA ... and variations across all therapeutic ...

This would increase transparency for consumers as well as the FDA's oversight of food ingredients considered to be safe, Kennedy said. "For far too long, ingredient manufacturers and sponsors have ...

Variations in regulatory requirements across ... and achieve quicker market entry . Leveraging FDA Fast Track and Accelerated Approval pathways Consultants can reduce drug development timelines ...

Recent advances in AI, including machine learning, natural language processing, and deep learning models, are transforming ...

With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO's market growth is driven by expanding indications and strategic partnerships. However, competition from ...

BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...

Purpose: The stability of a triamcinolone acetonide mouthwash and its efficacy in treating oral lichen planus are described. Results: The mouthwash had a satisfactory shelf life and was well ...